Metraipolis › archive › dc_689bfe1a381c

Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma — Europe PMC PMID:40867295

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40867295
DOI
10.3390/cancers17162668
License (as archived)
solo-consultazione
Archived
2026-11-10T14:20:04.818Z
SHA-256 of the archived text
b8750d475e7d236ff5e5d9bc12ed380546633e42e5bbe944f3ab3c0aa43aa500
Stable URL of this page
https://metraipolis.com/documento/dc_689bfe1a381c

How to cite

Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma — Europe PMC PMID:40867295 — Europe PMC (en), https://europepmc.org/article/MED/40867295 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_689bfe1a381c (Metraipolis archive dc_689bfe1a381c, sha256 b8750d475e7d236ff5e5d9bc12ed380546633e42e5bbe944f3ab3c0aa43aa500)
BibTeX
@misc{dc689bfe1a381c,
  title = {Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma — Europe PMC PMID:40867295},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40867295},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_689bfe1a381c; sha256 b8750d475e7d236ff5e5d9bc12ed380546633e42e5bbe944f3ab3c0aa43aa500},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40867295. Agents can read the archived copy with the MCP tool read_document.